SWOG clinical trial number
SWOG-8108

Evaluation of Bisantrene Hydrochloride in Refractory Multiple Myeloma

Closed
Phase
Published
Abbreviated Title
Evaluation of Bisantrene Hydrochloride in Refractory Multiple Myeloma
Activated
06/02/1982
Closed
03/16/1984

Publication Information Expand/Collapse

1991

Phase II evaluation of bisantrene in refractory multiple myeloma. A Southwest Oncology Group study.

BGM Durie;J Crowley;C Coltman, Jr;RA Chapman;SP Balcerzak;JD Bonnet;DA Lipschitz;RL Stephens;BD Cheson IND 9:329-331

1983

Southwest Oncology Group studies with Bisantrene.

CA Coltman Jr;D Cowan;DD Von Hoff;GM Durie;TP Miller;E Surwit;DS Alberts;RA Shildt;F Panettiere;GM Mills;PB Wasserman;TM McDaniel In: 13th International Congress of Chemotherapy (Vienna, August 28-September 2, 1983). KH Spitzy, K Karrer, eds. Symposium Bisantrene 213:1-4